# The Efficacy of YiQiFuMai Injection as an Adjunctive Treatment for Sepsis

> **NCT05265130** · PHASE4 · UNKNOWN · sponsor: **Xiyuan Hospital of China Academy of Chinese Medical Sciences** · enrollment: 80 (estimated)

## Conditions studied

- Sepsis

## Interventions

- **DRUG:** YiQiFuMai
- **DRUG:** 0.9% Normal Saline 250ml

## Key facts

- **NCT ID:** NCT05265130
- **Lead sponsor:** Xiyuan Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-28
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-10-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05265130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05265130, "The Efficacy of YiQiFuMai Injection as an Adjunctive Treatment for Sepsis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05265130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*